Target Price | $6.63 |
Price | $2.48 |
Potential |
167.34%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Prokidney 2026 .
The average Prokidney target price is $6.63.
This is
167.34%
register free of charge
$10.50
323.39%
register free of charge
$1.01
59.27%
register free of charge
|
|
A rating was issued by 14 analysts: 9 Analysts recommend Prokidney to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Prokidney stock has an average upside potential 2026 of
167.34%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 0.08 | 0.33 |
316.13% | ||
EBITDA Margin | -216,150.00% | -53,573.35% |
75.21% | ||
Net Margin | -76,487.50% | -45,377.22% |
40.67% |
9 Analysts have issued a sales forecast Prokidney 2025 . The average Prokidney sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Prokidney EBITDA forecast 2025. The average Prokidney EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2024 | -216,150.00% | |
---|---|---|
2025 |
-53,573.35%
75.21%
Unlock
|
9 Prokidney Analysts have issued a net profit forecast 2025. The average Prokidney net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.62 | -0.52 |
8.77% | 16.13% | |
P/E | negative | |
EV/Sales | 1,307.10 |
9 Analysts have issued a Prokidney forecast for earnings per share. The average Prokidney EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Sep 30 2024 |
Guggenheim |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
B of A Securities |
Locked
➜
Locked
|
Locked | Sep 04 2024 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Jul 15 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 14 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Jul 09 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 30 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 30 2024 |
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 10 2024 |
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.